Similarly, PRDM14 was recently added to a gene panel utilized, also in clinical trials, for the diagnosis of lung cancer through the analysis of DNA hypermethylation of biomarkers in sputum, thus denoting its silencing in these tumors [210,211,212]. Here, PRDM14 is linked to lung cancer.